NRX Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • NRX Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$847K, a 60.1% decline year-over-year.
  • NRX Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.56M, a 35.8% increase year-over-year.
  • NRX Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.31M, a 150% decline from 2022.
  • NRX Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $4.58M, a 79.8% decline from 2021.
  • NRX Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $22.7M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.31M -$6.89M -150% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $4.58M -$18.2M -79.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $22.7M +$23.1M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$390K -$1.6M -132% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $1.21M +$117K +10.7% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-14
2018 $1.09M Jan 1, 2018 Dec 31, 2018 10-K 2019-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.